Drug development for hearing loss
Ended Project Grant Awarded Last action
- Award ID
- R43DC018258
- Recipient
-
Novear Therapeutics LLC UEI YJ2ANN4WF959
- Awarding agency
-
National Institute on Deafness and Other Communincation Disorders
National Institutes of Health, Department of Health and Human Services
- Obligated
- $150,100
Award facts
- Assistance listing
- 93.173 Research Related to Deafness and Communication Disorders
- Completion date
- Place of performance
- Illinois, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $74,729 | |
| Amendment | $74,729 | |
| Amendment | -$74,729 | |
| Amendment | -$74,729 | |
| Amendment | -$74,729 | |
| Amendment | $0 | |
| Amendment | $28,394 | |
| Original award | $196,435 |
Quick answers
Who received award R43DC018258?
R43DC018258 was awarded to Novear Therapeutics LLC by National Institute on Deafness and Other Communincation Disorders (National Institutes of Health) on September 1, 2019.
How much is award R43DC018258 worth?
$150,100 has been obligated on R43DC018258.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award